Atlas Trials

the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle

Clinical trial NCT05032937 · COMPLETED

Trial details

NCT number
NCT05032937
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Coronary Heart Disease
Start date
2021-10-13
Primary completion
2022-11-05
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.